14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £141.16 £183.01 Friday, 31st Mar 2023 AGY.L stock ended at £6.25. During the day the stock fluctuated 0% from a day low at £6.25 to a day high of £6.25.
90 days £141.16 £227.30
52 weeks £84.73 £227.30

Historical Allergy Therapeutics plc prices

Date Open High Low Close Volume
Mar 31, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 30, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 29, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 28, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 27, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 24, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 23, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 22, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 21, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 20, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 17, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 16, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 15, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 14, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 13, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 10, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 09, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 08, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 07, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 03, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 02, 2023 £6.25 £6.25 £6.25 £6.25 0
Mar 01, 2023 £6.25 £6.25 £6.25 £6.25 0
Feb 28, 2023 £6.25 £6.25 £6.25 £6.25 0
Feb 27, 2023 £6.25 £6.25 £6.25 £6.25 0
Feb 24, 2023 £6.25 £6.25 £6.25 £6.25 0
Click to get the best stock tips daily for free!

About Allergy Therapeutics plc

Allergy Therapeutics plc Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, P... AGY.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT